BULL Pharmachem

Enzalutamide 40 mg capsules are an oral medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptor signaling, preventing testosterone from stimulating cancer cell growth. Enzalutamide is commonly prescribed for patients with prostate cancer that no longer responds to hormone therapy.

Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.

Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.

Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.

Osimertinib tablets are used to treat non-small cell lung cancer (NSCLC) with specific mutations in the EGFR gene, particularly the T790M mutation. It works by inhibiting the mutated EGFR receptor, blocking cancer cell growth and spread. It’s commonly prescribed for advanced or metastatic NSCLC.

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

Nintedanib is a potent, orally administered tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and certain non-small cell lung cancers. It slows disease progression by inhibiting pathways that drive fibrosis and abnormal tissue remodeling.

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.

Nintedanib is a potent, orally administered tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and certain non-small cell lung cancers. It slows disease progression by inhibiting pathways that drive fibrosis and abnormal tissue remodeling.

Nintedanib is a potent, orally administered tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and certain non-small cell lung cancers. It slows disease progression by inhibiting pathways that drive fibrosis and abnormal tissue remodeling.

Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.

Lenvatinib is a powerful multi-kinase inhibitor used to treat advanced cancers, including thyroid, liver, and kidney cancers. It works by blocking tumor angiogenesis and cell proliferation, effectively slowing disease progression and extending survival in patients with difficult-to-treat solid tumors.

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

Additional Information:

• Port of Dispatch: Mumbai

Ibrutinib capsules are used to treat various cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It works by inhibiting Bruton's tyrosine kinase, blocking cancer cell growth and promoting cell death in affected lymphocytes.

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Sorafenib tablets are an oral medication used primarily to treat advanced kidney cancer, liver cancer, and thyroid cancer. It works by inhibiting cancer cell growth and blood vessel formation, slowing tumor progression. It's also used for certain types of hepatocellular carcinoma.

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Fludarabine Phosphate Injection is a purine analog used in treating chronic lymphocytic leukemia and certain lymphomas. It inhibits DNA synthesis, leading to cancer cell death. Its precision in targeting malignant cells makes it a key agent in hematologic malignancy management and bone marrow conditioning regimens.

Trifluridine and tipiracil is an oral chemotherapy combination used to treat metastatic colorectal and gastric cancers. Trifluridine disrupts cancer cell DNA, while tipiracil enhances its efficacy by preventing degradation. This therapy extends survival in patients unresponsive to standard treatments, offering renewed clinical hope.

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Everolimus tablets are immunosuppressive drugs used to prevent organ rejection after transplants and treat certain cancers (e.g., breast, kidney, pancreatic). They inhibit mTOR, blocking cell growth and proliferation, reducing tumor growth and enhancing graft survival.